Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi (ONCSM.IS)
- Previous Close
88.30 - Open
88.30 - Bid 86.25 x --
- Ask 86.55 x --
- Day's Range
84.55 - 88.55 - 52 Week Range
84.55 - 215.00 - Volume
108,826 - Avg. Volume
396,102 - Market Cap (intraday)
2.064B - Beta (5Y Monthly) 0.88
- PE Ratio (TTM)
-- - EPS (TTM)
-2.50 - Earnings Date --
- Forward Dividend & Yield 0.41 (0.44%)
- Ex-Dividend Date Nov 8, 2023
- 1y Target Est
--
Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi provides consumables, medical devices, diagnostic products, and protective equipment. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system; OncoCare Set, a chemotherapy preparation and administration consumables; and Oncocare Infusion Pump. It also provides Oncosem components, such as pinch clamps, roller clamps, 3/4 way connectors, vial adapters, drip chambers, hydrophobic caps, male and rotating luer locks, spikes, taxol filters, check valves, and covers. The company was incorporated in 2008 and is headquartered in Ankara, Turkey.
www.oncosem.comRecent News: ONCSM.IS
View MorePerformance Overview: ONCSM.IS
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is BIST 100 (XU100.IS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ONCSM.IS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ONCSM.IS
View MoreValuation Measures
Market Cap
2.11B
Enterprise Value
2.11B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.62
Price/Book (mrq)
7.68
Enterprise Value/Revenue
5.63
Enterprise Value/EBITDA
56.76
Financial Highlights
Profitability and Income Statement
Profit Margin
-15.80%
Return on Assets (ttm)
0.77%
Return on Equity (ttm)
-19.44%
Revenue (ttm)
374.49M
Net Income Avi to Common (ttm)
-59.17M
Diluted EPS (ttm)
-2.50
Balance Sheet and Cash Flow
Total Cash (mrq)
44.66M
Total Debt/Equity (mrq)
17.00%
Levered Free Cash Flow (ttm)
49.13M